Cynapsus raises $63M in U.S. listing

Cynapsus Therapeutics Inc. (TSX:CTH; NASDAQ:CYNA) gained $0.64 to $14.64 in its first day of trading Thursday on NASDAQ after it raised $63 million through the sale of 4.5 million shares at $14 in an offering underwritten by BofA Merrill Lynch; Nomura; and Noble Life Science Partners. The offering price valued Cynapsus at $160 million. The company filed last month to raise up to $60 million. ...